SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Interim Management Statement

16 May 2012 07:00

RNS Number : 4417D
Xchanging PLC
16 May 2012
 



 

16 May 2012

 

Xchanging plc

Interim Management Statement

 

Xchanging plc ('Xchanging'), the business process and technology services provider and integrator, today issues its Interim Management Statement covering the period from 1 January 2012 to date.

 

Current Trading and Outlook

Trading in the first four months of the year has been in line with our expectations. There have been no material changes to the financial position of the Group in the period.

 

Our Insurance business continues to perform well. The initiative to develop a Global Insurance Accounting and Settlement platform supported by Deutsche Bank progresses well and we plan to launch at the beginning of next year.

 

Financial Services has begun the year as expected and we have benefitted from the savings created last year, as planned.

 

In Technology services, we are accelerating the investment in our insurance software and in improving our market presence.

 

In Procurement, we continue to invest in the initial implementation stage of the new contracts with L'Oréal in Europe and BAE Systems in North America.

 

Ken Lever, Chief Executive, commented: "We have seen a steady start to the year as we pursue our agenda of building the foundations for growth.  Our objectives in 2012 are to demonstrate that we can compete to win in our chosen markets and to achieve year-on-year improvement in financial performance."

 

The company's AGM will take place at 10:00 am today at Xchanging's head office at 34 Leadenhall Street, London EC3A 1AX.

 

 

Enquiries

Xchanging plc Tel: +44 (0) 207 780 6999

David Bauernfeind, Chief Financial Officer

Alexandra Hockenhull, Head of Corporate Communications

and Investor Relations

 

Maitland Tel: +44 (0) 207 379 5151

Neil Bennett

George Hudson

Emma Burdett

 

Conference Call

David Bauernfeind and Alexandra Hockenhull will host a conference call for analysts and investors to discuss this Interim Management Statement at 08:00 BST on Wednesday 16 May 2012. The conference call telephone number is +44 (0)1452 555 566 and conference ID is 81735163.

 

For individuals unable to participate in the conference call, a telephone replay will be available until Wednesday 23 May 2012. Please telephone +44 (0)1452 550 000 (conference ID 81735163#).

 

 

Xchanging Investor Relations App

Please visit the App Store to download Xchanging's IR app.

 

 

About Xchanging

Xchanging is a business process and technology service provider and integrator specialising in Financial Services, Insurance Services, Technology and Procurement, with processing skills and capabilities applicable to other vertical industry and market sectors.

 

www.xchanging.com 

Cautionary Statement: 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Xchanging's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approval or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUNVVRUOAVARR
Date   Source Headline
7th Apr 20157:00 amRNSMM4 amendment to earn-out terms
1st Apr 20152:06 pmRNSBlocklisting Interim Review
31st Mar 20154:54 pmRNSTotal Voting Rights
27th Mar 201511:09 amRNSDirector/PDMR Shareholding
24th Mar 20157:03 amRNSCMA provisional clearance
18th Mar 201511:48 amRNSDirector/PDMR Shareholding
18th Mar 201511:45 amRNSDirector/PDMR Shareholding
16th Mar 20159:46 amRNSDirector/PDMR Shareholding
11th Mar 20153:07 pmRNSTotal Voting Rights
5th Mar 20154:57 pmRNSHolding(s) in Company
3rd Mar 201510:58 amRNSDirector/PDMR Shareholding
27th Feb 20155:27 pmRNSDirector Declaration
26th Feb 20157:01 amRNSAcquisition
26th Feb 20157:01 amRNSFinal Results
13th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 20157:00 amRNSAcquisition of Spikes Cavell
3rd Feb 20157:00 amRNSBlocklisting Interim Review
3rd Feb 20157:00 amRNSHolding(s) in Company
30th Jan 201511:43 amRNSHolding(s) in Company
27th Jan 20156:28 pmRNSHolding(s) in Company
23rd Dec 20143:01 pmRNSDirector/PDMR Shareholding
19th Dec 20147:00 amRNSAcquisition of Total Objects completed
9th Dec 20143:09 pmRNSTotal Objects Acquisition to Complete
5th Dec 20144:03 pmRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSAgencyport CMA Referral
3rd Dec 20141:48 pmRNSHolding(s) in Company
2nd Dec 20143:14 pmRNSAgencyport CMA Update
27th Nov 201410:51 amRNSDirector/PDMR Shareholding
27th Nov 20147:00 amRNSInvestor Seminar
26th Nov 201412:46 pmRNSTotal Voting Rights
21st Nov 20141:01 pmRNSDirector Declaration
14th Nov 20147:51 amRNSWorkers' Compensation contract
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20145:12 pmRNSBlocklisting Interim Review
20th Oct 20142:59 pmRNSDirector/PDMR Shareholding
3rd Oct 201412:20 pmRNSBlocklisting Interim Review
1st Oct 20147:00 amRNSAgencyport CMA Order
24th Sep 20144:36 pmRNSDirector/PDMR Shareholding
17th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 201410:21 amRNSHolding(s) in Company
29th Aug 201411:11 amRNSDirector/PDMR Shareholding
12th Aug 20145:21 pmRNSTotal Voting Rights
1st Aug 20141:04 pmRNSBlocklisting Interim Review
31st Jul 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSTakes full ownership of Fondsdepot Bank
14th Jul 20145:31 pmRNSHolding(s) in Company
8th Jul 20147:00 amRNSMM4 amendment to earn-out terms
4th Jul 20147:00 amRNSAcquisition
3rd Jul 20147:00 amRNSAcquisition
24th Jun 20145:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.